TOMI Highlights 30% Hantavirus Exposure and Ebola Outbreak Driving SteraMist Demand

A peer-reviewed study found 30% seroprevalence of Sin Nombre virus in rodents across eastern Washington and Idaho, with active infections in 10% of samples spanning farm and wilderness settings. These results underscore elevated airborne and surface contamination risks in grain silos, storage facilities, manufacturing plants and rural commercial buildings.

The ongoing Ebola emergency in Central Africa is spreading rapidly, prompting healthcare systems, transportation hubs, hospitality operators and government agencies to seek scalable, high-level decontamination solutions for complex indoor environments. Institutions are prioritizing technologies capable of addressing diffuse and structurally embedded pathogen threats.

The convergence of heightened hantavirus exposure risks and escalating Ebola cases is driving interest in TOMI’s SteraMist platform, which uses ionized hydrogen peroxide to deliver hospital-grade decontamination. TOMI expects this surge in public health threats to accelerate adoption across hospitals, cruise ships, airports, agricultural cooperatives and remediation sectors.

Invented under a DARPA defense grant, SteraMist’s Binary Ionization Technology employs a low-percentage hydrogen peroxide fog to produce a visual, non-caustic germ-killing aerosol for indoor surface disinfection. TOMI’s prior success containing an Ebola outbreak under a USAID grant and collaborations with global health agencies reinforce its reputation as a trusted health security provider.